Literature DB >> 7590863

Serum nitrite plus nitrate in infection with human immunodeficiency virus type-1.

R Zangerle1, D Fuchs, G Reibnegger, G Werner-Felmayer, H Gallati, H Wachter, E R Werner.   

Abstract

To get a measure of the extent of induction of nitric oxide synthase in infection with human immunodeficiency virus type-1 (HIV-1) in vivo, we estimated serum nitrite plus nitrate concentrations in 110 HIV-1 infected individuals compared to 76 blood donors. To monitor cytokine action and to measure induction of pteridine synthesis, we determined in parallel neopterin, biopterin, soluble tumor necrosis factor-alpha receptor 55 and 75, and beta 2-microglobulin. Serum nitrite plus nitrate concentrations were elevated in patients as compared to blood donor controls. In sera of patients, nitrite plus nitrate levels correlated significantly with neopterin, soluble tumor necrosis factor receptor 55 and 75, and beta 2-microglobulin. Nitrite plus nitrate levels were higher and correlations were stronger in groups of patients with lower CD4+ cell count. These results suggest that cytokine-mediated nitric oxide synthesis occurs in individuals with HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590863     DOI: 10.1016/S0171-2985(11)80155-5

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  9 in total

1.  Metabolic Profiling of Human Blood by High Resolution Ion Mobility Mass Spectrometry (IM-MS).

Authors:  Prabha Dwivedi; Albert J Schultz; Herbert H Hill
Journal:  Int J Mass Spectrom       Date:  2010-12       Impact factor: 1.986

2.  Nitric oxide synthesis enhances human immunodeficiency virus replication in primary human macrophages.

Authors:  D Blond; H Raoul; R Le Grand; D Dormont
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 3.  Molecular and cellular mechanisms of neuronal cell death in HIV dementia.

Authors:  W Li; D Galey; M P Mattson; A Nath
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

4.  Interleukin-17A is associated with flow-mediated dilation and interleukin-4 with carotid plaque in persons with HIV.

Authors:  Celestine N Wanjalla; Tecla M Temu; Mona Mashayekhi; Christian M Warren; Bryan E Shepherd; Rama Gangula; Hubaida Fuseini; Samuel Bailin; Curtis L Gabriel; Pandu Gangula; Meena S Madhur; Spyros Kalams; Simon A Mallal; David G Harrison; Joshua A Beckman; John R Koethe
Journal:  AIDS       Date:  2022-02-14       Impact factor: 4.632

5.  CCTTT-repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesis.

Authors:  M Hersberger; S Bonhoeffer; S K Rampini; M Opravil; J Marti-Jaun; A Telenti; E Hänseler; B Ledergerber; R F Speck
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

6.  Nitric oxide and chronic HCV and HIV infections.

Authors:  G Lake-Bakaar; D Sorbi; V Mazzoccoli
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.487

7.  Type I Interferon Supports Inducible Nitric Oxide Synthase in Murine Hepatoma Cells and Hepatocytes and during Experimental Acetaminophen-Induced Liver Damage.

Authors:  Malte Bachmann; Zoe Waibler; Thomas Pleli; Josef Pfeilschifter; Heiko Mühl
Journal:  Front Immunol       Date:  2017-07-31       Impact factor: 7.561

8.  Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients.

Authors:  Ajay Wanchu; Archana Bhatnagar; Madhu Khullar; Archana Sud; Pradeep Bambery; Surjit Singh
Journal:  BMC Infect Dis       Date:  2002-07-29       Impact factor: 3.090

Review 9.  Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms.

Authors:  Johanna M Gostner; Kathrin Becker; Katharina Kurz; Dietmar Fuchs
Journal:  Front Psychiatry       Date:  2015-07-14       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.